
Evolva - Nature sustained
EVOLVA AND LALLEMAND CLOSE THE SALE OF EVOLVA AG TO DANSTAR FERMENT AG ON 28 DECEMBER 2023
Evolva Holding AG
THIS IS THE WEBSITE OF EVOLVA HOLDING SA. FOLLOWING THE ACQUISITION OF EVOLVA AG BY A SUBSIDIARY OF LALLEMAND INC. WHICH CLOSED ON 28 DECEMBER 2023, THE INFORMATION CONTAINED HEREIN RELATES TO THE ACTIVITIES OF THE HOLDING, INCLUDING AD HOC ANNOUNCEMENTS, FINANCIAL REPORT AND …
Press Releases - Evolva Holding AG
Oct 29, 2024 · Head to topContactContact
Investors - Evolva Holding AG
Financial information Our aim is to inform in a timely and accurate manner about the development of Evolva Holding SA.
Newsroom - Evolva Holding AG
Feb 21, 2025 · News Ad hoc and corporate press releases of Evolva Holding AG.Contact
Board of Directors - Evolva Holding AG
At the Annual General Meeting of Evolva Holding SA on 12 April 2024, shareholders re-elected the existing board members Stephan Schindler and Beat In-Albon as board members and re-elected Stephan Schindler as Chairman.
After the sale of Evolva AG, for the financial year 2023, the only area involving assumptions and estimates that can have a significant impact on the consolidated financial statements is the estimate of the costs to complete the liquidation of the company.
NootkaShield™ nootkatone | Evolva
NootkaShield™ production combines Evolva’s innovative yeast fermentation process with a proprietary conversion technique. CDC research has determined that nootkatone is effective at repelling and controlling a range of insect pests including ticks, mosquitoes, and …
Nootkatone by Evolva - Evolva Holding AG
By producing nootkatone via precision fermentation, rather than extracting it from the skin of grapefruits, Evolva’s process allows Nootkatone to be made in large amounts in a highly …
Evolva to acquire Allylix
Evolva (SIX: EVE) has agreed to acquire San Diego-based Allylix, Inc., a privately held yeast fermentation company with a focus on high-value ingredients, in an all-stock transaction. The acquisition will immediately expand Evolva’s product and IP portfolio and enhance the competitiveness of Evolva’s stevia products.